Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of inhaled Aviptadil on the immunologic activity of alveolar macrophages in sarcoidosis
DRKS00000184Phase 2Completed
- Sponsor
- mondoBIOTECH AG
- Start
- Aug 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of aviptadil in sarcoidosis, sponsored by mondoBIOTECH AG. Primary endpoint: Immunologic activity of alveolar macrophages. Started Aug 2009; status: completed.
02
Drugs
aviptadil
03
Conditions
sarcoidosis
Beyond the preview
Go deeper on DRKS00000184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000184.